| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cartesian Therapeutics, Inc. | Director | Common Stock | 5,800 | $44,080 | $7.60 | 16 Dec 2025 | Direct |
| Cartesian Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 17,200 | 16 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics, Inc. | 16 Dec 2025 | 2 | $0 | 4 | Director | 18 Dec 2025, 17:05 |
| RNAC | Cartesian Therapeutics, Inc. | 16 Dec 2025 | 0 | $0 | 3 | Director | 18 Dec 2025, 17:03 |